Potential applicable range of oncolytic virotherapy with a recombinant measles virus in dogs

被引：0
|
作者：
Fujiyuki, Tomoko [1 ]
Shoji, Koichiro [1 ]
Iizuka, Keigo [2 ]
Horikirizono, Yu [2 ]
Sato, Hiroki [1 ]
Asano, Kazushi [2 ]
Yoneda, Misako [1 ]
Kai, Chieko [1 ]
机构：
[1] UT, IMSUT, Lab Anim Res Cent, Tokyo, Japan
[2] Nihon Univ, Dept Vet Med, Col Bioresource Sci, Vet Surg, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2416
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [1] A recombinant oncolytic measles virus for novel virotherapy
    Kai, Chieko
    [J]. CANCER SCIENCE, 2018, 109 : 805 - 805
  • [2] Measles virus: Background and oncolytic virotherapy
    Bhattacharjee, Sankhajit
    Yadava, Pramod Kumar
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2018, 13 : 58 - 62
  • [3] Production and purification of measles virus for oncolytic virotherapy clinical trials
    Langfield, KK
    Wegman, TR
    Walker, HJ
    Griesmann, GE
    Sauer, JA
    Stephan, SA
    Federspiel, MJ
    [J]. MOLECULAR THERAPY, 2004, 9 : S31 - S31
  • [4] Measles as a potential oncolytic virus
    Fielding, AK
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2005, 15 (02) : 135 - 142
  • [5] Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
    Russell, Stephen J.
    Babovic-Vuksanovic, Dusica
    Bexon, Alice
    Cattaneo, Roberto
    Dingli, David
    Dispenzien, Angela
    Deyle, David R.
    Federspiel, Mark J.
    Fielding, Adele
    Galanis, Eva
    Lacy, Martha Q.
    Leibovich, Bradley C.
    Liu, Minetta C.
    Munoz-Alia, Miguel
    Miest, Tanner C.
    Molina, Julian R.
    Mueller, Sabine
    Okuno, Scott H.
    Packiriswamy, Nandakumar
    Peikert, Tobias
    Raffel, Corey
    Van Rhee, Frits
    Ungerechts, Guy
    Young, Paul R.
    Zhou, Yumei
    Peng, Kah-Whye
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (09) : 1834 - 1839
  • [6] Oncolytic virotherapy for targeting ovarian cancer using fully folate receptor targeted recombinant measles virus
    Hasegawa, Kosei
    Nakamura, Takafumi
    Harvey, Mary
    Hongo, Atsushi
    Figini, Mariangela
    Canervari, Silvana
    Peng, Kah-Whye
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [7] Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
    Kochneva, Galina
    Sivolobova, Galina
    Tkacheva, Anastasiya
    Grazhdantseva, Antonina
    Troitskaya, Olga
    Nushtaeva, Anna
    Tkachenko, Anastasiya
    Kuligina, Elena
    Richter, Vladimir
    Koval, Olga
    [J]. ONCOTARGET, 2016, 7 (45) : 74171 - 74188
  • [8] Oncolytic measles virotherapy for ovarian cancer
    Peng, KW
    Myers, R
    Frenke, M
    Greiner, S
    Harvey, M
    Soeffker, D
    Galanis, E
    Federspiel, M
    Russell, SJ
    [J]. CANCER GENE THERAPY, 2004, 11 (12) : 846 - 846
  • [9] Improved Manufacturing of Measles Virus for Human Oncolytic Virotherapy Clinical Trials
    Langfield, K. L.
    Walker, H. J.
    Stephan, S. A.
    Melder, D. C.
    Sauer, J. A.
    Whitcomb, L. S.
    Griesmann, G. E.
    Gregory, L. C.
    Federspiel, M. J.
    [J]. HUMAN GENE THERAPY, 2011, 22 (10) : A32 - A32
  • [10] Oncolytic Virotherapy with Recombinant Measles Virus Induces Tumor Antigen-Specific T-Cell Responses
    Packiriswamy, Nandakumar
    Upreti, Deepak
    Zhou, Yumei
    Khan, Rehan
    Miller, Amber
    Diaz, Rosa M.
    Rooney, Cliona M.
    Dispenzieri, Angela
    Peng, Kah Whye
    Russell, Stephen J.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 32 - 33
12345